Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment

4M ago

SLRX

PremiumPre-Earnings

SLRX Earnings this Week: How Will it Perform?

6M ago

SLRX

PremiumPress Releases

Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program

6M ago

SLRX

PremiumPress Releases

Salarius Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides a Business Update

9M ago

SLRX

$Salarius Pharmaceuticals Receives FDA Clearance of SP-3164 Investigational New Drug Application to Begin a Phase 1 Clinical Trial in Relapsed/Refractory Non-Hodgkin Lymphoma Patients$

PremiumPress Releases

Salarius Pharmaceuticals Receives FDA Clearance of SP-3164 Investigational New Drug Application to Begin a Phase 1 Clinical Trial in Relapsed/Refractory Non-Hodgkin Lymphoma Patients

10M ago

SLRX

More SLRX News >

SLRX News on the Web

2024-03-25

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

InvestorPlace

Neutral

2024-03-23

SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q4 2023

InvestorPlace

Neutral

2024-02-09

Salarius Pharmaceuticals Inc at Ladenburg Thalmann Healthcare Conference Transcript

GuruFocus News

Neutral

2024-02-09

Q2 2022 Salarius Pharmaceuticals Inc Earnings Call Transcript

GuruFocus News

Neutral

2024-02-09

Q1 2022 Salarius Pharmaceuticals Inc Earnings Call Transcript

GuruFocus News

Neutral

2024-02-09

Salarius Pharmaceuticals Inc Asset Acquisition Agreement with DeuteRx LLC - M&A Call Transcript

GuruFocus News

Neutral

2024-02-09

Q4 2021 Salarius Pharmaceuticals Inc Earnings Call Transcript

GuruFocus News

Neutral

2024-02-09

Q3 2021 Salarius Pharmaceuticals Inc Earnings Call Transcript

GuruFocus News

Neutral

News Score - Last 7 Days

Neutral

SLRX

Sector Average

Media Buzz

This Week1 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average64%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SLRX’s Media Buzz Sentiment?

1 articles about SLRX were published this week. In an average week, 1 articles are published.

What is SLRX’s weekly average amount of articles?

In an average week, 1 articles about SLRX are published.

What is SLRX’s News Sentiment?

50% of articles about SLRX were positive this week, compared to its sector average of 64%.

Healthcare Stocks that are Trending in the News

STROSutro Biopharma

MASIMasimo

THRDThird Harmonic Bio, Inc.

STOKStoke Therapeutics

BCABBioAtla

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing